Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: Public health and global perspectives

BMC Medical Ethics

Volumn 5, Issue , 2004, Pages 1-7

  Verma, Geetika ^a   Upshur, Ross E G ^a,b   Rea, Elizabeth ^a   Benatar, Solomon R ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; DIRECTLY OBSERVED THERAPY; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN RIGHTS; INTERNATIONAL COOPERATION; MEDICAL ETHICS; PUBLIC HEALTH; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 2942568121     PISSN: 14726939     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6939-5-1     Document Type: Article

References (43)

1. Porter JD, McAdam KP: The re-emergence of tuberculosis. Annu Rev Public Health 1994, 15:303-323.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC: Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999, 282:677-686.
3. Rubel AJ, Garro LC: Social and cultural factors in the successful control of tuberculosis. Public Health Rep 1992, 107:626-636.
4. Booker MJ: Compliance, coercion, and compassion: moral dimensions of the return of tuberculosis. J Med Humanit 1996, 17:91-102.
5. Bayer R, Dupuis L: Tuberculosis, public health, and civil liberties. Annu Rev Public Health 1995, 16:307-326.
6. Khan A, Walley J, Newell J, Imdad N: Tuberculosis in Pakistan: socio-cultural constraints and opportunities in treatment. Soc Sci Med 2000, 50:247-254.
7. Croft RA, Croft RP: Expenditure and loss of income incurred by tuberculosis patients before reaching effective treatment in Bangladesh. Int J Tuberc Lung Dis 1998, 2:252-254.
8. Rajeswari R, Balasubramanian R, Muniyandi M, Geetharamani S, Thresa X, Venkatesan P: Socio-economic impact of tuberculosis on patients and family in India. Int J Tuberc Lung Dis 1999, 3: 869-877.
9. Annas GJ: Control of tuberculosis - the law and the public's health. N Engl J Med 1993, 328:585-588.
10. A human rights approach to TB; guidelines for social mobilization Geneva: World Health Organization, Stop TB Partnership Secretariat; 2001.
11. Min K: The white plague returns: law and the new tuberculosis. Washington Law Review 1994, 69:1121-1142.
12. Reilly R: Combating the tuberculosis epidemic: the legality of coercive treatment measures. Columbia Journal of Law and Social Problems 1993, 27:101-149.
13. Harris J, Holm S: Is there a moral obligation not to infect others? BMJ 1995, 311:1215-1217.
14. Kass NE: An ethics framework for public health. Am J Public Health 2001, 91:1776-1782.
15. Childress JF, Faden RR, Gaare RD, Gostin LO, Kahn J, Bonnie RJ, Kass NE, Mastroianni AC, Moreno JD, Nieburg P: Public health ethics: mapping the terrain. J Law Med Ethics 2001, 30:170-178.
16. Centre for Evidence-Based Medicine: Levels of evidence and grades of recommendation. [http://www.minervation.com/cedm/docs/levels.html].
17. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994, 330:1179-1184.
18. Dye C, Garnett GP, Sleeman K, Williams BG: Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 1998, 352:1886-1891.
19. Khatri G, Frieden T: Controlling tuberculosis in India. N Eng J Med 2002, 347:1420-1425.
20. Walley JD, Khan MA, Newell JN, Khan MH: Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001, 357:664-669.
21. Khan J, Akhtar S, Fayyaz Hussain S: Direct observation for tuberculosis treatment. Lancet 2001, 358(9279):421-422.
22. Lerner BH, Gulick RM, Dubler NN: Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med 1998, 129:573-578.
23. Volmink J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2001, 4(1 CD003343. Review.):.
24. Oscherwitz T, Tulsky JP, Roger S, Sciortino S, Alpers A, Royce S, Lo B: Detention of persistently nonadherent patients with tuberculosis. JAMA 1997, 278:843-846.
25. Volmink J, Garner P: Interventions for promoting adherence to tuberculosis management. Cochrane Database Syst Rev 2000, 4(CD 000010. Review):.
26. Lerner BH: Catching patients: tuberculosis and detention in the 1990s. Chest 1999, 115:236-241.
27. Gasner MR, Maw KL, Feldman GE, Fujiwara PI, Frieden TR: The use of legal action in New York City to ensure treatment of tuberculosis. N Engl J Med 1999, 340:359-366.
28. Singleton L, Turner M, Haskal R, Etkind S, Tricarico M, Nardell E: Long-term hospitalization for tuberculosis control. Experience with a medical-psychosocial inpatient unit. JAMA 1997, 278:838-842.
29. Maher D, Uplekar M, Blanc L, Raviglione M: Treatment of tuberculosis. BMJ 2003, 327:822-823.
30. Garner P, Volmink J: Directly observed therapy for tuberculosis. BMJ 2003, 327:823-824.
31. Coker R: Detention and mandatory treatment for tuberculosis patients in Russia. Lancet 2001, 358:349-350.
32. Gostin LO: The resurgent tuberculosis epidemic in the era of AIDS: reflections on public health, law, and society. MD Law Rev 1995, 54:1-131.
33. Upshur RE: Principles for the justification of public health intervention. Can J Public Health 2002, 93:101-103.
34. Loff B, Burris S: Compulsory detention: limits of law. Lancet 2001, 358:146.
35. Tangwa G: Bioethics: an African perspective. Bioethics 1996, 10:183-200.
36. Sen A: Human rights and Asian values: What Lee Kuan Yew and Le Peng don't understand about Asia. [http://www.fsa.ulaval.ca/personnel/vernag/REF/Textes/Amartya.Sen.html].
37. Chee C, James L: The Singapore Tuberculosis Elimination Programme: the first five years. Bull World Health Organ 2003, 81:217-221.
38. Doyal L: Moral problems in the use of coercion in dealing with nonadherence in the diagnosis and treatment of tuberculosis. Ann N Y Acad Sci 2001, 953:208-215.
39. Benatar SR: Prospects for global health: lessons from tuberculosis. Thorax 1995, 50:487-489.
40. Benatar SR: Respiratory health in a globalizing world. Am J Respir Crit Care Med 2001, 163:1064-1067.
41. White GL Jr, Henthorne BH, Barnes SE, Segarra JT: Tuberculosis: a health education imperative returns. J Community Health 1995, 20:29-57.
42. Benatar SR: Global disparities in health and human rights: a critical commentary. Am J Public Health 1998, 88:295-300.
43. The Return of the White Plague: Global Poverty and the New Tuberculosis. Edited by: Gandy M, Zumla A.Verso London, New York; 2003.